22 May 2013
Keywords: bayer, sues, abbott, slice, humira, earnings, healthcare
Article | 12 January 2009
Bayer HealthCare has filed a law suit against the USA's Abbott Laboratories alleging that the latter's lead drug Humira (adalimumab)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
21 May 2013
© 2013 thepharmaletter.com